The global human leukocyte antigen (HLA) typing for the transplant market is anticipated to grow at a CAGR of around 6.5% during the forecast period (2021-2027). The factors augmenting the growth of the global HLA typing for the transplant market are the increasing demand for transplant diagnostic products and the increase in transplant procedures owing to the rising geriatric population coupled with organ failures. According to the Population Reference Bureau’s Population Bulletin, the number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060. Hence, the elderly population is more prone to age-related diseases and they are at high risk of organ failures, due to this the growth in demand for HLA typing such as PCR-based molecular assays for transplant procedures can be witnessed during the forecast period. Moreover, the continuous technological advancements in molecular diagnosis will increase the use of HLA typing for transplant.
Browse the full report description of "Global HLA Typing for Transplant Market Size, Share & Trends Analysis Report By Type (Molecular Assays, and Non-Molecular Assays) By Product & Services (Reagents, Software, and Instruments) By Application (Diagnostics, and Research) By End-Users (Academic Institutes & Research Centers, Hospitals & Transplant Centers, and others) Forecast, 2021-2027" at https://www.omrglobal.com/industry-reports/hla-typing-transplant-market
Moreover, the key market players are also contributing towards the growth of the HLA typing for transplant market by adopting various strategies such as new product launches, business expansion, and partnership collaboration. For instance, Omixon announced the new distribution channels in Mexico and India to further accelerating its international commercial expansion of Omixon’s high-performance, high-throughput, and high-resolution multi-sample kit and software products for HLA genotyping analysis by NGS. Moreover, in October 2020, Thermo Fisher Scientific signed a partnership agreement with Terasaki Innovation Center (TIC). Through this partnership, Thermo Fisher Scientific will facilitate the discovery and development of tools to diagnose and manage transplant patients. These key strategies are expected to create considerable growth in the market during the forecast period.
Market Coverage
o By Technology
o By Product & Services
o By Applications
o By End-Users
o North America
o Europe
o Asia-Pacific
o Rest of the World
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global HLA typing for Transplant Market Report Segment
By Technology
o Serological Assays
o Mixed Lymphocyte Culture Assays
o PCR-Based Molecular Assay
? Sequence-Specific Primer (SSP-PCR)
? Sequence-Specific Oligonucleotide (SSO-PCR)
? Sequence-Based Typing (SBT-PCR)
? Others
o Sequencing-Based Molecular Assays
? Sanger Sequencing
? Next-Generation Sequencing
By Product & Services
By Application
By End-Users
Global HLA typing for Transplant Market Report by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/hla-typing-transplant-market